Literature DB >> 1993798

A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.

J S Forrester1, M Fishbein, R Helfant, J Fagin.   

Abstract

Angioplasty causes substantial injury to the coronary artery intima and media that is unrecognizable by angiography. On the basis of a substantial body of research in oncology and wound healing, it is hypothesized that restenosis is a manifestation of the general wound healing response expressed specifically in vascular tissue. The temporal response to injury occurs in three characteristic phases: inflammation, granulation and extracellular matrix remodeling. The specific expression of these phases in the coronary artery leads to intimal hyperplasia at 1 to 4 months. The major milestones in the temporal sequence of restenosis are platelet aggregation, inflammatory cell infiltration, release of growth factors, medial smooth muscle cell modulation and proliferation, proteoglycan deposition and extracellular matrix remodeling. Each step has potential inhibitors that could be used for preventive therapy. Resolution of restenosis, however, probably requires both creation of the largest possible residual lumen and substantial inhibition of intimal hyperplasia.

Entities:  

Mesh:

Year:  1991        PMID: 1993798     DOI: 10.1016/s0735-1097(10)80196-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  56 in total

1.  Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.

Authors:  D G Macejak; H Lin; S Webb; J Chase; K Jensen; T C Jarvis; J M Leiden; L Couture
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography.

Authors:  P W Serruys; D P Foley; P J de Feyter
Journal:  Br Heart J       Date:  1992-10

4.  In vitro study of role of trace amount of Cu release from Cu-bearing stainless steel targeting for reduction of in-stent restenosis.

Authors:  Ling Ren; Lu Xu; Jingwen Feng; Yang Zhang; Ke Yang
Journal:  J Mater Sci Mater Med       Date:  2012-02-23       Impact factor: 3.896

5.  Angioplasty and restenosis.

Authors:  A J Brady; J B Warren
Journal:  BMJ       Date:  1991-09-28

6.  Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration.

Authors:  Balachandar Venkatesan; Anthony J Valente; Venkatapuram Seenu Reddy; Deborah A Siwik; Bysani Chandrasekar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-26       Impact factor: 4.733

Review 7.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

8.  Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.

Authors:  Jun Ma; Nan Zhao; Lexxus Betts; Donghui Zhu
Journal:  J Mater Sci Technol       Date:  2015-12-24       Impact factor: 8.067

Review 9.  Coronary restenosis and gene therapy.

Authors:  W Mazur; N M Ali; A E Raizner; B A French
Journal:  Tex Heart Inst J       Date:  1994

10.  Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

Authors:  M W Chang; E Barr; M M Lu; K Barton; J M Leiden
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.